Summary
Former President Donald Trump's executive order to separate combination childhood vaccines like MMR faces strong condemnation from public health experts and significant logistical and financial challenges for drugmakers, parents, and providers. Experts state there is no scientific basis for the change, which would require pharmaceutical companies to revive old individual vaccine productions and build new manufacturing plants, a process estimated to take years and tens of millions of dollars.
